Ocutec

Developer of Polyethylene Glycol (PEG)-based ocular lens

placeBellshill, Scotland, United Kingdom calendar_todayFounded 2001 groups9 employees language ocutec.com

Registered entities

Innovation

63 patent families (12 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace steady. Cited 499 times.

YearFilings
201315
201411
20159
201610
20177
20181
20191
20204
20213
20231
20242
20251

Investor mix

32 investors on record; lead investors include Deepbridge Capital.

Investor typeCountShare
Venture capital26%
Private equity13%
Angel & family office13%
Bank & private debt13%
Other / undisclosed2784%
Coming soon